Xconomy National

Archives

by in

Entry	Author	Date	Location
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare	Arlene Weintraub	05/20/11	New York
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit	Arlene Weintraub	05/12/11	New York
FDA Panel Meets Today on Vertex HepC Drug	Ryan McBride	04/28/11	Boston
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate	Ryan McBride	04/20/11	Boston
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference	Gregory T. Huang	04/14/11	Boston
Roche Vet Takes CEO Job at Boston’s Enlight Biosciences	Ryan McBride	04/12/11	Boston
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News	Bruce V. Bigelow	03/31/11	San Diego
As Kinsella Affair Goes Global, Sofinnova’s Papiernik Says Don’t Blame Big Pharma for Weak Biotech Ventures	Bruce V. Bigelow	03/30/11	San Diego
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai	Ryan McBride	03/10/11	Boston
Verenium Returning to San Diego, Entra Health Systems Expands Use of Wireless Blood Sugar Test, Genomatica Raises $45M, & More San Diego Life Sciences News	Bruce V. Bigelow	03/03/11	San Diego
Avalon’s Kinsella Upbraids Big Pharma, Scripps Names Marletta to Succeed Lerner, CalciMedica Scores $6M, & More San Diego Life Science News	Bruce V. Bigelow	02/24/11	San Diego
Avalon’s Kinsella Calls Out Big Pharma for “Bad Behavior” That’s Pushing Biotech Ventures “Almost to Point of Extinction”	Bruce V. Bigelow	02/17/11	San Diego
Biotech Vet Gerngross Dishes Out More Details On Latest VC-Backed Startup Arsanis	Ryan McBride	02/15/11	Boston
Eisai, with Oncology Group H3 Biomedicine, Doubles Down on Boston	Ryan McBride	02/14/11	Boston
Relay: An App for Finding the Next Top Scientists and Discoveries	Ryan McBride	01/04/11	Boston
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners	Ryan McBride	12/15/10	Boston
Ann Arbor Hosts “World’s Largest” Biz Plan Contest This Week, $1M-Plus for Winners	Ryan McBride	12/09/10	Detroit
Dicerna Expands Kyowa Hakko Pact	Ryan McBride	12/07/10	Boston
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box	Ryan McBride	11/15/10	Boston
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights	Ryan McBride	10/28/10	Boston
Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner	Ryan McBride	10/21/10	Detroit
Startup Ligon Discovery Lands Bayer Schering for First Deal with Major Pharma	Ryan McBride	09/29/10	Boston
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars	Ryan McBride	09/28/10	Boston
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J	Ryan McBride	09/09/10	Boston
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area	Ryan McBride	09/01/10	Boston
Nonprofits and the Valley of Death in Drug Discovery	Walter Moos	08/19/10	San Francisco
Susan Windham-Bannister on the State of the State’s $1B Life Sciences Initiative, Part II	Ryan McBride	08/18/10	Boston
Of Genzyme, Sanofi-Aventis, Biotech Buyout Gossip, and Angry Patients	Ryan McBride	08/05/10	Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?	Ryan McBride	07/29/10	Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology	Ryan McBride	07/15/10	Boston
Page 1 of 2	next page »